| Title: | Prediagnostic Plasma Metabolites Are Associated with Incident Hepatocellular Carcinoma: A Prospective Analysis. |
| Journal: | Cancer Prevention Research |
| Published: | 7 Feb 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/39916630/ |
| DOI: | https://doi.org/10.1158/1940-6207.capr-24-0440 |
Publication 15188
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
Despite increasing incidence of hepatocellular carcinoma (HCC) in vulnerable populations, accurate early detection tools are lacking. We aimed to investigate the associations between prediagnostic plasma metabolites and incident HCC in a diverse population. In a prospective, nested case-control study within the Southern Community Cohort Study, we conducted prediagnostic LC/MS metabolomic profiling in 150 incident HCC cases (median time to diagnosis, 7.9 years) and 100 controls with cirrhosis. Logistic regression assessed metabolite associations with HCC risk. Metabolite set enrichment analysis identified enriched pathways, and a random forest classifier was used for risk classification models. Candidate metabolites were validated in the UK Biobank (N = 12 incident HCC cases and 24 cirrhosis controls). In logistic regression analysis, seven metabolites were associated with incident HCC (MeffP < 0.0004), including N-acetylmethionine (OR = 0.46; 95% confidence interval, 0.31-0.66). Multiple pathways were enriched in HCC, including histidine and CoA metabolism (FDR P < 0.001). The random forest classifier identified 10 metabolites for inclusion in HCC risk classification models, which improved HCC risk classification compared with clinical covariates alone (AUC = 0.66 for covariates vs. 0.88 for 10 metabolites plus covariates; P < 0.0001). Findings were consistent in the UK Biobank (AUC = 0.72 for covariates vs. 0.88 for four analogous metabolites plus covariates; P = 0.04), assessed via nuclear magnetic resonance spectroscopy. Prediagnostic metabolites, primarily amino acid and sphingolipid derivatives, are associated with HCC risk and improve HCC risk classification beyond clinical covariates. These metabolite profiles, detectable years before diagnosis, could serve as early biomarkers for HCC detection and risk stratification if validated in larger studies. Prevention Relevance: Our findings support the need for larger prospective studies examining the role of prediagnostic plasma metabolomics for the preventive management of HCC in diverse patients across multiple etiologies of liver disease. This approach could improve HCC care by identifying metabolic changes years before diagnosis, potentially enhancing screening and early detection practices.</p>
15 Keywords
- Adult
- Aged
- Biomarkers, Tumor
- Carcinoma, Hepatocellular
- Case-Control Studies
- Early Detection of Cancer
- Female
- Humans
- Incidence
- Liver Neoplasms
- Male
- Metabolome
- Metabolomics
- Middle Aged
- Prospective Studies
10 Authors
- Robert M Wilechansky
- Prasanna K Challa
- Xijing Han
- Xinwei Hua
- Alisa K Manning
- Kathleen E Corey
- Raymond T Chung
- Wei Zheng
- Andrew T Chan
- Tracey G Simon
1 Application
| Application ID | Title |
|---|---|
| 92681 | Methods development for gene-environment interaction analysis on cloud platforms |
Enabling scientific discoveries that improve human health